Kellen Scott 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Kellen Scott
CFO & Secretary
Transactions
- Award
Stock Option (right to buy)
2025-06-01+225,000→ 225,000 totalExercise: $4.11Exp: 2035-05-31→ Common Shares (225,000 underlying)
Holdings
- 32,290
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026.